Listed
Stock Code: 322970
| Company Name | 주식회사 무진메디 |
| English Name | Moogene Medi Co., Ltd. |
| Business Reg. No. | 5418700496 |
| CEO | 윤태종 |
| Address | 경기도 하남시 미사강변중앙로7번안길 25씨동 10층(풍산동,유-테크밸리씨타워) |
| Industry | 의학 및 약학 연구개발업 |
| Industry Code | 70113 |
| Main Products | 유전자편집기술 |
| Established | 20160622 |
| Phone | 031-8027-6150 |
| Website | www.moogene.com/ |
| Regular Employees | 18persons |
| Corp. Reg. No. | 1101116098324 |
Venture Certified
| 기술평가보증기업(기금) | 2016-08-26 ~ 2018-08-25 | 20160109914 | 2016-08-26 |
| 기술평가보증기업(기금) | 2018-08-26 ~ 2020-08-25 | 20180110322 | 2016-08-26 |
| 벤처투자유형 | 2020-08-26 ~ 2022-08-25 | 20200300858 | 2016-08-26 |
| 벤처투자유형 | 2022-08-26 ~ 2025-08-25 | 20220728010008 | 2016-08-26 |
| 벤처투자유형 | 2025-08-26 ~ 2028-08-25 | 20250805010029 | 2016-08-26 |
Revenue CAGR +141.4%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 1.2B | 1.4B | 0.2B |
| Operating Profit | -29B | -24B | -29B |
| Net Profit | -62B | -26B | -30B |
| Total Assets | 93B | 155B | 74B |
| Total Liabilities | 53B | 53B | 63B |
| Total Equity | 40B | 102B | 11B |
Operating Loss: Op. profit -29B
3 Consecutive Years of Net Loss
Debt Ratio Surge (+80pp YoY)
▲ 45.6%
▼ 10.0%
▲ 69.1%
▼ 58.5%
▼ 2.5%
| Name | Position | Role | Comp. (M KRW) |
|---|---|---|---|
| 윤태종 | 사내이사 | 경영 총괄 | - |
| 조영석 | 사내이사 | 임상 총괄 | - |
| 박지훈 | 사내이사 | 경영관리 본부장 | - |
| 정창호 | 감사 | 감사 | - |
| Shareholder | Ownership (%) | Shares Held |
|---|---|---|
| - |
| Regular Employees | 18persons |
| CEO | 윤태종 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "경기도 하남시",
"ceo_name": "윤태종",
"certificate": [
{
"cert_number": "20160109914",
"changes": "",
"disclosure_date": "2016-08-26",
"first_cert_date": "2016-08-26",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2016-08-26 ~ 2018-08-25"
},
{
"cert_number": "20180110322",
"changes": "",
"disclosure_date": "2018-08-29",
"first_cert_date": "2016-08-26",
"no": "2",
"type": "기술평가보증기업(기금)",
"valid_period": "2018-08-26 ~ 2020-08-25"
},
{
"cert_number": "20200300858",
"changes": "",
"disclosure_date": "2020-07-30",
"first_cert_date": "2016-08-26",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2020-08-26 ~ 2022-08-25"
},
{
"cert_number": "20220728010008",
"changes": "",
"disclosure_date": "2022-07-28",
"first_cert_date": "2016-08-26",
"no": "4",
"type": "벤처투자유형",
"valid_period": "2022-08-26 ~ 2025-08-25"
},
{
"cert_number": "20250805010029",
"changes": "",
"disclosure_date": "2025-08-05",
"first_cert_date": "2016-08-26",
"no": "5",
"type": "벤처투자유형",
"valid_period": "2025-08-26 ~ 2028-08-25"
}
],
"company_name": "주식회사 무진메디",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 4319168000,
"cost_of_sales": 0,
"current_assets": 121758000,
"current_liabilities": 3039184000,
"gross_profit": 20000000,
"net_income": -3027866000,
"net_income_bs": -3027867000,
"non_current_assets": 7301955000,
"non_current_liabilities": 3299890000,
"non_operating_expenses": 132170000,
"non_operating_income": 3718000,
"operating_profit": -2899414000,
"revenue": 20000000,
"sga_expenses": 2919414000,
"total_assets": 7423713000,
"total_equity": 1084639000,
"total_liabilities": 6339074000
},
"2023": {
"capital_stock": 6064771000,
"cost_of_sales": 0,
"current_assets": 3367258000,
"current_liabilities": 4881453000,
"gross_profit": 140038000,
"net_income": -2576745000,
"net_income_bs": -2576745000,
"non_current_assets": 12158144000,
"non_current_liabilities": 420514000,
"non_operating_expenses": 173074000,
"non_operating_income": 850000,
"operating_profit": -2404521000,
"revenue": 140038000,
"sga_expenses": 2544559000,
"total_assets": 15525403000,
"total_equity": 10223436000,
"total_liabilities": 5301967000
},
"2024": {
"capital_stock": 6067619000,
"cost_of_sales": 0,
"current_assets": 460962000,
"current_liabilities": 4771888000,
"gross_profit": 116522000,
"net_income": -6229624000,
"net_income_bs": -6229623000,
"non_current_assets": 8807443000,
"non_current_liabilities": 503771000,
"non_operating_expenses": 3327717000,
"non_operating_income": 16517000,
"operating_profit": -2918424000,
"revenue": 116522000,
"sga_expenses": 3034946000,
"total_assets": 9268405000,
"total_equity": 3992746000,
"total_liabilities": 5275658000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [
{
"amount": "1,300,000,000",
"changes": "1,300,000,000",
"date": "2022-04-15"
},
{
"amount": "300,000,000",
"changes": "300,000,000",
"date": "2022-04-15"
},
{
"amount": "850,000,000",
"changes": "850,000,000",
"date": "2020-05-26"
},
{
"amount": "850,000,000",
"changes": "850,000,000",
"date": "2020-05-26"
},
{
"amount": "1,000,000,000",
"changes": "1,000,000,000",
"date": "2020-04-02"
},
{
"amount": "1,000,000,000",
"changes": "1,000,000,000",
"date": "2020-03-06"
},
{
"amount": "1,000,000,000",
"changes": "1,000,000,000",
"date": "2020-03-03"
}
],
"main_products": "유전자편집기술",
"phone": "031-8027-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 4/10 | Primary Source: DART | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| DART Financial | 2026-02-27 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |